Gitlab Inc
For the period ended Jan 31, 2024. Filed Mar 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 26, 2024
GTLB$46.66-1.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Fiscal Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||
| Net loss, including amounts attributable to noncontrolling interest | $(428,033) | $(180,696) | $(157,560) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||
| Stock-based compensation expense | 163,049 | 122,567 | 30,009 |
| Gain from the fair value change of acquisition related contingent consideration | — | (1,722) | — |
| Charitable donation of common stock | 10,700 | — | — |
| Amortization of intangible assets | 2,167 | 2,362 | 665 |
| Depreciation expense | 4,368 | 3,231 | 543 |
| Amortization of deferred contract acquisition costs | 43,463 | 44,958 | 33,368 |
| Gain from deconsolidation of Arch, formerly Meltano | — | (17,798) | — |
| Loss from equity method investment | 3,824 | 3,189 | — |
| Impairment of equity method investment | 8,858 | — | — |
| Net amortization of premiums or discounts on short-term investments | (20,349) | (6,077) | — |
| Unrealized foreign exchange loss (gain), net | 4,648 | (3,727) | 20,389 |
| Other non-cash expense, net | 1,330 | 1,156 | 197 |
| Changes in assets and liabilities: | |||
| Accounts receivable | (36,341) | (54,169) | (38,223) |
| Prepaid expenses and other current assets | (23,854) | (8,909) | (8,219) |
| Deferred contract acquisition costs | (53,100) | (48,555) | (42,575) |
| Other non-current assets | (309) | 3,012 | (3,374) |
| Accounts payable | (3,443) | 287 | 1,877 |
| Accrued expenses and other current liabilities | 258,293 | 4,619 | 13,953 |
| Accrued compensation and benefits | 15,173 | (11,693) | 19,755 |
| Deferred revenue | 79,347 | 73,003 | 79,074 |
| Other non-current liabilities | 5,249 | (2,446) | 307 |
| Net cash provided by (used in) operating activities | 35,040 | (77,408) | (49,814) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||
| Purchases of short-term investments | (815,697) | (821,622) | (100,031) |
| Proceeds from maturities of short-term investments | 734,007 | 231,626 | 50,000 |
| Purchases of property and equipment | (1,598) | (6,070) | (3,541) |
| Deconsolidation of Arch, formerly Meltano | — | (9,620) | — |
| Escrow payment related to business combination, after acquisition date | (2,500) | — | — |
| Payments for business combination, net of cash acquired and consideration withheld in an escrow | — | — | (323) |
| Other investing activities | (450) | — | — |
| Net cash used in investing activities | (86,238) | (605,686) | (53,895) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||
| Proceeds from initial public offering, net of underwriting discounts | — | — | 654,552 |
| Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases | 32,302 | 24,515 | 25,354 |
| Issuance of common stock under employee stock purchase plan | 12,933 | 14,378 | — |
| Proceeds from warrants exercised | — | — | 86 |
| Repurchase of common stock in a tender offer | — | — | (590) |
| Contributions received from noncontrolling interests, net of issuance costs | — | 61,726 | 26,450 |
| Partial settlement of acquisition related contingent cash consideration | — | (3,137) | — |
|---|---|---|---|
| Payments of deferred offering costs | — | — | (4,667) |
| Net cash provided by financing activities | 45,235 | 97,482 | 701,185 |
| Impact of foreign exchange on cash and cash equivalents | (3,943) | (3,658) | 6,846 |
| Net increase (decrease) in cash and cash equivalents | (9,906) | (589,270) | 604,322 |
| Cash, cash equivalents, and restricted cash at beginning of period | 297,902 | 887,172 | 282,850 |
| Cash, cash equivalents, and restricted cash at end of period | $287,996 | $297,902 | $887,172 |
| Supplemental disclosure of cash flow information: | |||
| Cash paid for income taxes | $6,903 | $838 | $1,310 |
| Cash donations | $— | $— | $1,000 |
| Supplemental disclosure of non-cash investing and financing activities: | |||
| Vesting of early exercised stock options | $1,234 | $4,706 | $7,212 |
| Issuance of common stock upon conversion of preferred stock | $— | $— | $424,904 |
| Unpaid property and equipment in accrued expenses | $— | $— | $273 |
| Unpaid deferred offering costs | $— | $— | $40 |
| Reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the amounts shown in the statements of cash flows above: | |||
| Cash and cash equivalents | $287,996 | $295,402 | $884,672 |
| Restricted cash, included in prepaid expenses and other current assets | — | 2,500 | — |
| Restricted cash, included in other non-current assets | — | — | 2,500 |
| Total cash, cash equivalents and restricted cash | $287,996 | $297,902 | $887,172 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.